vs
Healthpeak Properties(DOC)与KAISER ALUMINUM CORP(KALU)财务数据对比。点击上方公司名可切换其他公司
KAISER ALUMINUM CORP的季度营收约是Healthpeak Properties的1.3倍($929.0M vs $702.9M),Healthpeak Properties净利率更高(51.6% vs 3.0%,领先48.6%),KAISER ALUMINUM CORP同比增速更快(21.4% vs -6.6%),过去两年KAISER ALUMINUM CORP的营收复合增速更高(12.2% vs 0.5%)
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
凯撒铝业是美国知名铝产品生产商,前身为凯撒铝业化工公司。其历史可追溯至Permanente Metals公司,该公司公开发行普通股后更名为凯撒铝业化工公司,后续拆分出现在的凯撒铝业,深耕铝材料生产领域,为下游多行业提供铝制品解决方案。
DOC vs KALU — 直观对比
营收规模更大
KALU
是对方的1.3倍
$702.9M
营收增速更快
KALU
高出28.0%
-6.6%
净利率更高
DOC
高出48.6%
3.0%
两年增速更快
KALU
近两年复合增速
0.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $702.9M | $929.0M |
| 净利润 | $363.0M | $28.2M |
| 毛利率 | — | 13.3% |
| 营业利润率 | 0.7% | 6.5% |
| 净利率 | 51.6% | 3.0% |
| 营收同比 | -6.6% | 21.4% |
| 净利润同比 | 28.3% | 42.4% |
| 每股收益(稀释后) | $0.28 | $1.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOC
KALU
| Q1 26 | $702.9M | — | ||
| Q4 25 | $719.4M | $929.0M | ||
| Q3 25 | $705.9M | $843.5M | ||
| Q2 25 | $694.3M | $823.1M | ||
| Q1 25 | $702.9M | $777.4M | ||
| Q4 24 | $698.0M | $765.4M | ||
| Q3 24 | $700.4M | $747.7M | ||
| Q2 24 | $695.5M | $773.4M |
净利润
DOC
KALU
| Q1 26 | $363.0M | — | ||
| Q4 25 | $114.0M | $28.2M | ||
| Q3 25 | $-117.1M | $39.5M | ||
| Q2 25 | $31.7M | $23.2M | ||
| Q1 25 | $42.8M | $21.6M | ||
| Q4 24 | $4.5M | $19.8M | ||
| Q3 24 | $85.9M | $8.8M | ||
| Q2 24 | $146.0M | $18.9M |
毛利率
DOC
KALU
| Q1 26 | — | — | ||
| Q4 25 | — | 13.3% | ||
| Q3 25 | 58.6% | 13.6% | ||
| Q2 25 | 60.2% | 12.2% | ||
| Q1 25 | 61.1% | 13.4% | ||
| Q4 24 | 60.3% | 12.5% | ||
| Q3 24 | 60.0% | 9.6% | ||
| Q2 24 | 60.6% | 13.4% |
营业利润率
DOC
KALU
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | 6.5% | ||
| Q3 25 | 9.2% | 5.8% | ||
| Q2 25 | 5.7% | 4.6% | ||
| Q1 25 | 7.7% | 5.3% | ||
| Q4 24 | -2.2% | 5.0% | ||
| Q3 24 | 14.1% | 1.8% | ||
| Q2 24 | 22.3% | 4.7% |
净利率
DOC
KALU
| Q1 26 | 51.6% | — | ||
| Q4 25 | 73.2% | 3.0% | ||
| Q3 25 | -16.6% | 4.7% | ||
| Q2 25 | 4.6% | 2.8% | ||
| Q1 25 | 6.1% | 2.8% | ||
| Q4 24 | 0.7% | 2.6% | ||
| Q3 24 | 12.3% | 1.2% | ||
| Q2 24 | 21.0% | 2.4% |
每股收益(稀释后)
DOC
KALU
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $1.67 | ||
| Q3 25 | $-0.17 | $2.38 | ||
| Q2 25 | $0.05 | $1.41 | ||
| Q1 25 | $0.06 | $1.31 | ||
| Q4 24 | $0.02 | $1.21 | ||
| Q3 24 | $0.12 | $0.54 | ||
| Q2 24 | $0.21 | $1.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $7.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.8B | $826.1M |
| 总资产 | $21.6B | $2.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DOC
KALU
| Q1 26 | $-1.2B | — | ||
| Q4 25 | $467.5M | $7.0M | ||
| Q3 25 | $91.0M | $17.2M | ||
| Q2 25 | $89.4M | $13.1M | ||
| Q1 25 | $70.6M | $21.3M | ||
| Q4 24 | $119.8M | $18.4M | ||
| Q3 24 | $180.4M | $45.7M | ||
| Q2 24 | $106.9M | $70.4M |
总债务
DOC
KALU
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — |
股东权益
DOC
KALU
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | $826.1M | ||
| Q3 25 | $7.6B | $806.1M | ||
| Q2 25 | $7.9B | $776.0M | ||
| Q1 25 | $8.2B | $756.8M | ||
| Q4 24 | $8.4B | $743.1M | ||
| Q3 24 | $8.6B | $729.4M | ||
| Q2 24 | $8.8B | $727.6M |
总资产
DOC
KALU
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | $2.6B | ||
| Q3 25 | $19.6B | $2.6B | ||
| Q2 25 | $19.8B | $2.5B | ||
| Q1 25 | $19.8B | $2.4B | ||
| Q4 24 | $19.9B | $2.4B | ||
| Q3 24 | $20.0B | $2.3B | ||
| Q2 24 | $20.2B | $2.3B |
负债/权益比
DOC
KALU
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-20.6M |
| 自由现金流经营现金流 - 资本支出 | — | $-51.1M |
| 自由现金流率自由现金流/营收 | — | -5.5% |
| 资本支出强度资本支出/营收 | 3.4% | 3.3% |
| 现金转化率经营现金流/净利润 | — | -0.73× |
| 过去12个月自由现金流最近4个季度 | — | $-25.5M |
8季度趋势,按日历期对齐
经营现金流
DOC
KALU
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $-20.6M | ||
| Q3 25 | $315.0M | $59.1M | ||
| Q2 25 | $363.5M | $15.9M | ||
| Q1 25 | $279.4M | $57.0M | ||
| Q4 24 | $1.1B | $43.4M | ||
| Q3 24 | $318.2M | $34.1M | ||
| Q2 24 | $316.2M | $26.3M |
自由现金流
DOC
KALU
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $-51.1M | ||
| Q3 25 | — | $34.5M | ||
| Q2 25 | — | $-27.7M | ||
| Q1 25 | — | $18.8M | ||
| Q4 24 | $333.7M | $-12.6M | ||
| Q3 24 | — | $-17.0M | ||
| Q2 24 | — | $-17.4M |
自由现金流率
DOC
KALU
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | -5.5% | ||
| Q3 25 | — | 4.1% | ||
| Q2 25 | — | -3.4% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 47.8% | -1.6% | ||
| Q3 24 | — | -2.3% | ||
| Q2 24 | — | -2.2% |
资本支出强度
DOC
KALU
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | 3.3% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | 105.6% | 7.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 5.7% |
现金转化率
DOC
KALU
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | -0.73× | ||
| Q3 25 | — | 1.50× | ||
| Q2 25 | 11.48× | 0.69× | ||
| Q1 25 | 6.52× | 2.64× | ||
| Q4 24 | 235.43× | 2.19× | ||
| Q3 24 | 3.71× | 3.88× | ||
| Q2 24 | 2.17× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
KALU
| Packaging | $440.6M | 47% |
| Aero Hs Products | $213.0M | 23% |
| Transferred Over Time | $200.2M | 22% |
| Automotive Extrusions | $75.4M | 8% |